Imperial Capital Continues Global Expansion Efforts with the Hiring of Two Senior Structured Products Professionals
29.6.2017 17:45 | NASDAQ OMX
LOS ANGELES, June 29, 2017 (GLOBE NEWSWIRE) -- Imperial Capital Group, LLC ("Imperial Capital"), and its affiliate, Imperial Capital (International) LLP ("Imperial UK"), announced today the addition of Itish Popat and Jason Kim to its Structured Products Group. Mr. Popat and Mr. Kim will report to Keith Grimaldi, Managing Director and Head of Structured Products Sales and Trading.
"We are pleased to welcome Itish and Jason to Imperial further complementing our existing Structured Products Group team," said Tom Corcoran, President of Imperial Capital, LLC. "Their deep understanding of structured products and robust industry experience will enable our firm to better serve the US and European institutional investor community as well as adapt to the ever evolving market."
Itish Popat joins Imperial UK as a Managing Director in the Structured Products Sales Group in London and brings more than 20 years of varietal capital markets experience. Most recently, Mr. Popat was a Partner and Head of ABS / Financials Agency Broking Business at Vantage Capital Markets LLP. Prior to Vantage Capital Markets, Mr. Popat was an Executive Director of Fixed Income Sales with UBS and Head of UK / Ireland ABS Sales, where he covered UK & Irish Banks, asset managers, SIV's, insurance companies, pension funds and hedge funds. Prior to joining UBS, Mr. Popat spent just under nine years with HSBC in Fixed Income Sales and Trading. Mr. Popat earned a BA(Hons) in Business Studies from the University of Portsmouth.
Jason Kim joins Imperial Capital, LLC as a Senior Vice President in the Structured Products Trading Group in New York and has over 15 years of experience trading a variety of fixed income products. Most recently, Mr. Kim was an Executive Director at Oppenheimer & Co. Inc. and primarily traded non-agency RMBS as well as CMBS, CLO and ABS bonds. Prior to Oppenheimer, he held similar roles at JVB Financial, UBS and Deutsche Bank. Mr. Kim earned a BA in Economics from Northwestern University and an MBA in Finance and Economics from the University of Chicago.
About Imperial Capital, LLC
Imperial Capital is a full-service investment bank offering a uniquely integrated platform of comprehensive services to institutional investors and middle market companies. We offer sophisticated sales and trading services to institutional investors and a wide range of investment banking advisory, capital markets and restructuring services to middle market corporate clients. Paired with our proprietary research and sales & trading desk analysis, we provide investment analysis across an issuer's capital structure, including bank loans, debt securities, the hybrid/bank capital marketplace (through our ELP Framework), post-reorganization equities, special situations claims and listed and unlisted equities. Our comprehensive and integrated service platform, expertise across the global capital structure, and deep industry sector knowledge enable us to provide clients with research driven ideas, superior advisory services, and trade execution. We are quick to identify opportunities under any market conditions and we have a proven track record of offering creative, proprietary solutions to our clients. Imperial Capital has three principal businesses: Investment Banking, Institutional Sales & Trading and Institutional Research. More information about Imperial Capital can be found at www.imperialcapital.com.
About Imperial Capital (International), LLP
Imperial Capital International, founded in 2011, is an affiliate of Imperial Capital, LLC with an office in central London. Complementing Imperial Capital's existing fixed income sales and trading franchise, Imperial Capital (International), LLP expanded the Imperial Capital franchise into the EEA. The company focuses on selling the entire credit spectrum and capital structure to its European institutional clients.
For more information regarding Imperial Capital, LLC, founded in 1997, please contact:
Chief Operating Officer
For more information regarding Imperial Capital (International), LLP, please contact:
44 (0) 207 650 5401
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Imperial Capital, LLC via Globenewswire
Om NASDAQ OMX
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra NASDAQ OMX
Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra NASDAQ OMX
Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs24.7.2017 22:05 | Pressemelding
Phase 2 data in older adults (E205) demonstrate adjuvants and 2-dose regimens significantly increase the magnitude, duration and quality of the RSV F Vaccine immune response New data demonstrate that Novavax' construct is a stable prefusogenic RSV F antigen, distinctive from other candidates, that elicits potent neutralizing antibody responses to multiple key epitopes Path forward for a Phase 2 efficacy trial in 2018 based on signal in COPD population identified in prior older adult clinical trials Phase 3 Prepare(TM) trial accelerating and now includes 80 sites across 11 countries allowing continuous enrollment across global seasons GAITHERSBURG, Md., July 24, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced positive topline data from its Phase 2 safety and immunogenicity trial of the RSV F Vaccine in older adults, new preclinical data on its RSV F Vaccin
Announcing the First U.S. Federally Regulated Exchange and Clearing House for Digital Currency Derivatives24.7.2017 21:51 | Pressemelding
LedgerX Receives U.S. Federal Government License to Trade, Clear and Settle Digital Currency Contracts NEW YORK, July 24, 2017 (GLOBE NEWSWIRE) -- LedgerX, the New York-based institutional trading and clearing platform for digital currencies, receives approval to operate the first U.S. federally-regulated exchange and clearing house for derivatives contracts settling in digital currencies. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/eafba6f5-a1ce-47da-81a0-0aaacfe7caef See Related Release: The U.S. Commodity Futures Trading Commission (CFTC) grants LedgerX LLC a Derivatives Clearing Organization license (DCO) to clear and physically settle digital currency-based financial instruments. LedgerX will be the first federally supervised options venue for bitcoin Participants in the Le
Oxford Immunotec Appoints Richard Wenstrup, MD, as Chief Medical Officer24.7.2017 15:00 | Pressemelding
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced the appointment of Richard Wenstrup, MD, as Chief Medical Officer. Dr. Wenstrup brings to Oxford Immunotec more than 20 years of clinical leadership experience, including over a decade within the diagnostics industry. Most recently, Dr. Wenstrup served as Executive Vice President, Chief Medical Officer, for Myriad Genetics, Inc., where he played a key leadership role and made substantial contributions across the company that helped drive and support a multi-fold increase in revenue over a decade. In addition to building and leading Myriad's clinical and medical affairs teams, Dr. Wenstrup was actively involved in the company's product development, M&A, and in-licensing activi
Minerva Neurosciences Announces Departure of Directors24.7.2017 14:30 | Pressemelding
WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced the resignation of two members of its board of directors, Michele Ollier and Nico Vandervelpen. Following the Company's recent public offering and the resultant improvement in its financial position, Dr. Ollier and Mr. Vandervelpen will step down to focus on their private equity activities. Their resignations are effective today. "We would like to thank Michele and Nico for their invaluable contributions to Minerva as a private company and as it has transitioned during the past three years from a venture capital-backed company to a publicly traded company that has advanced several assets into late-stage clinical development," said Marc Beer, chairman of Minerva. About Minerva Neurosciences
French Energy Operator GRDF Enlists Appian's Low-code Platform for Enterprise-wide Deployment24.7.2017 14:00 | Pressemelding
RESTON, Va., July 24, 2017 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announces that leading French gas distributor GRDF will deploy its latest enterprise application developed on Appian's low-code platform. The new application is designed to manage the extension of gas distribution networks in France, and will be deployed to more than 2,500 users across GRDF. This marks GRDF's fifth major application deployed on the Appian Platform. GRDF is already benefitting from Appian's low-code applications, which enhance the customer experience and transform traditional business methods to more efficient and agile processes. Appian provides GRDF with the speed needed to capitalize on opportunities that the digital world presents, as well as the power to streamline complex business processes. Jean-Marc Wojtecki, Deputy CIO at GRDF, commented: "We solidly believe in the power of low-code for building new applications quickly. Appian allows us to innovate more effici
Placetel is named as a leading UC solution in Germany by ISG Experton Group24.7.2017 10:00 | Pressemelding
Placetel, Powered by BroadSoft, named as a leader in the "ISG Provider Lens Germany 2017 - Cloud Transformation / Operation Services & XaaS" Study recognizes broad functional spectrum and strong focus on SMEs Operation of data centers in Germany is acknowledged as a further advantage COLOGNE, Germany, July 24, 2017 (GLOBE NEWSWIRE) -- Placetel, a cloud PBX service from BroadSoft Germany GmbH, has been named by ISG/Experton Group, a leading fully integrated research, advisory and consulting company, as one of the best cloud-based solutions for Unified Communications as a Service (UCaaS) in Germany. ISG/Experton Group positioned Placetel, powered by BroadSoft, in the leadership quadrant in its provider comparison "ISG Provider Lens Germany 2017 - Cloud Transformation / Operation Services & XaaS". An infographic accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attach
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom